Stock Evaluator: Globus Medical, Inc. (GMED)

Globus Medical, Inc. GMED

$78.79 -1.47 -1.83%
July 31, 2026 4:00:03 PM EST November 10, 2021 Volume: 1,054,232
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Commentary & Analysis


Financial Summary

Share Statistics GMED Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $10,695.3 $337.2 78%
Shares Out (Mil) 138.2 41.9 69%
Institutional Ownership 82.6% 77.8% 51%
Float (Mil) 111.7 34.7 63%
Beta 1.00 0.85 60%
Avg Daily Volume (000s) 1,240 278 75%
Price Change
(52-week)
47.4% 58.7% 79%
Growth GMED Industry
Median
Percentile
(All Stocks)
Sales (5yr) 30.1% 11.8% 90%
Net Income (5yr) 39.4% (5.8%) 90%
EPS (5yr) 31.2% 11.4% 82
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (44.7%) (16.3%) 9%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 15 15 15
Current EPS $1.099 $4.740 $5.145
Month Ago EPS $1.098 $4.743 $5.145
# Rev Up 0 0 0
# Rev Down 0 2 1
Three Months Ago EPS $1.060 $4.472 $4.950
Year/Year Chg 22.1% 20.9% 44.8%
Financials GMED Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $3,101 $152 67%
Net Income (TTM) (Mil) $587 ($10) 81%
EPS (TTM) $4.350 ($0.500) 85%
Operating Cash Flow (TTM) (Mil) $779 ($2) 78%
Net Cash Flow (TTM) (Mil) $100 $1 77%
Long-Term Debt (Q1) (Mil) $101 $22 45%
Enterprise Value (Q1) (Mil) $9,892 $304 74%
Valuation GMED Industry
Median
Percentile
(All Stocks)
P/B 2.26 2.80 55%
P/E 18.4 31.1 46%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 0.6 1.9 28%
Ratios GMED Industry
Median
Percentile
(All Stocks)
Gross Margin 68.5% 59.1% 80%
Net Margin 18.9% (7.3%) 78%
ROA 11.6% (13.7%) 90%
ROE 13.3% (15.8%) 67%
Liabilities to Assets 13.0% 44.7% 8%
F-Score 8 4 94%

Globus Medical, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors